C11H15O5P

It is used to synthesize a new prostaglandin thromboxane A2 agonist. Sulprostone intermediate

C10H16BNO2S

C6H10O4

Dolutegravir intermediate

C18H27N4NaO23P4

is a P2Y2 receptor agonist, which activates P2Y2 receptor on the ocular surface, leading to rehydration through activation of the fluid pump mechanism of the accessory lacrimal glands on the conjunctival surface.

C17H19N3O6

Nicotinic α4β2 acetylcholine receptor partial agonist. Aid in smoking cessation.

C25H46N6O7

An organoammonium salt obtained by combining perindopril with one molar equivalent of L-arginine, is a complex compound of Perindopril , having the antihypertensive, cardiovascular protective and antithrombotic properties

C19H32N2O5.C4H11N

An angiotensin-converting enzyme (ACE) inhibitor. Antihypertensive.

C26H37NO3.C4H4O4

Fesoterodine fumarate is an antimuscarinic agent and is rapidly de-esterified to its active metabolite 5-hydroxymethyl tolterodine that is a muscarinic receptor antagonist.

C12H13N.CH4O3S

Rasagiline mesylate is a potent and selective irreversible monoamine oxidase B (MAO-B) inhibitor

C13H8N6

Topiroxostat is an orally-administered, non-purine, selective xanthine oxidase (XO) inhibitor

C20H24N4O4

Itraphylline is a new A2A receptor antagonist

C22H22F3N.HCl

Cinacalcet is the first entry in a new class of therapeutic agents called the calcimimetics. It was launched as an oral treatment for secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease on dialysis and for hypercalcemia in patients with parathyroid carcinoma.

C26H40O4

Obeticholic Acid intermediate-3

C33H46O4

Obeticholic Acid intermediate

C25H40O4

Obeticholic Acid intermediate-2